David Sprouse, PA
Physician Assistant · University Place, WANPI 1528256807
Payments from drug & device makers
Across 148 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$701
- Novartis$359
- Johnson & Johnson$318
- Amgen$296
- Regeneron Healthcare Solutions, Inc.$113
- Lilly USA, LLC$95
- plus $566 from 11 others
What the payments were for
- Food & beverage$2,34996%
- Education$1004%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 56 | $701 |
| Novartis | 20 | $359 |
| Johnson & Johnson | 19 | $318 |
| Amgen | 13 | $296 |
| Regeneron Healthcare Solutions, Inc. | 4 | $113 |
| Lilly USA, LLC | 6 | $95 |
| UCB, Inc. | 5 | $88 |
| Boehringer Ingelheim | 4 | $81 |
| Sun Pharmaceutical Industries Inc. | 3 | $78 |
| Sanofi | 2 | $67 |
| Pfizer | 3 | $58 |
| Organon | 5 | $49 |
| E.r. Squibb & Sons, L.L.C. | 2 | $37 |
| Incyte Corporation | 2 | $35 |
| Dermavant Sciences, Inc. | 2 | $33 |
| Merz North America, Inc. | 1 | $20 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $19 |
How this compares
$2,449 in reported general payments places this provider in the 90th percentile of 2,741 physician assistant providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Skyrizi PenRisankizumab-Rzaa | 21 | $452,460 |
| Dupixent PenDupilumab | 56 | $249,881 |
| Cosentyx Unoready PenSecukinumab | 15 | $206,650 |
| Dupixent SyringeDupilumab | 18 | $70,454 |
| Clobetasol Propionate | 74 | $3,091 |
| Acitretin | 14 | $2,557 |
| Tacrolimus | 12 | $1,938 |
| Ciclopirox | 28 | $1,926 |
| Calcipotriene | 17 | $1,780 |
| Ketoconazole | 72 | $1,224 |
| Betamethasone Dipropionate | 16 | $793 |
| Doxycycline Monohydrate | 18 | $586 |
| Triamcinolone Acetonide | 72 | $584 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 24 | $487 |
| Azithromycin | 13 | $390 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in University Place
- Jill KandoraShoreline$437K
- Jeannette HartRichland$263K
- Lance KeckTacoma$162K
- Erinn KingSeattle$129K
- Christy VathSeattle$75K
- Scott TaylorMercer Island$71K
- Gina FragioneGraham$69K
- Regan BrownSpokane$56K
- Justin ChapinSeattle$40K
- Susan DuffyBellevue$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.